Why Biomarker-Guided Strategies Shape the Future of Randomized Controlled Trials for Immunomodulating Therapies

{"title":"Why Biomarker-Guided Strategies Shape the Future of Randomized Controlled Trials for Immunomodulating Therapies","authors":"Erik H.A. Michels MD , Rombout B.E. van Amstel MD","doi":"10.1016/j.chstcc.2025.100131","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"3 2","pages":"Article 100131"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788425000048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}